CoChat

Targeting Breast Cancer and Their Stem Cell Population through AMPK Activation: Novel Insights

Open access

The DOI matches its Crossref record; 186 of the 189 references it cites were found in a registry or an index.

Abstract

Despite some significant advancements, breast cancer has become the most prevalent cancer in the world. One of the main reasons for failure in treatment and metastasis has been attributed to the presence of cancer initiating cells-cancer stem cells. Consequently, research is now being focussed on targeting cancer cells along with their stem cell population. Non-oncology drugs are gaining increasing attention for their potent anticancer activities. Metformin, a drug commonly used to treat type 2 diabetes, is the best example in this regard. It exerts its therapeutic action by activating 5' adenosine monophosphate-activated protein kinase (AMPK). Activated AMPK subsequently phosphorylates and targets several cellular pathways involved in cell growth and proliferation and the maintenance of stem-like properties of cancer stem cells. Therefore, AMPK is emerging as a target of choice for developing effective anticancer drugs. Vanadium compounds are well-known PTP inhibitors and AMPK activators. They find extensive applications in treatment of diabetes and obesity via PTP1B inhibition and AMPK-mediated inhibition of adipogenesis. However, their role in targeting cancer stem cells has not been explored yet. This review is an attempt to establish the applications of insulin mimetic vanadium compounds for the treatment of breast cancer by AMPK activation and PTP1B inhibition pathways.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells11030576

Cites

186 of 186 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Breast cancer stem cells, or cancer-initiating cells, display an innate ability to evade and survive all treatment strategies owing to their stem-like properties. They function to maintain the cancer cell population while regenerating themselves continuously.
Figure 1 Breast cancer stem cells, or cancer-initiating cells, display an innate ability to evade and survive all treatment strategies owing to their stem-like properties. They function to maintain the cancer cell population while regenerating themselves continuously.CC BY · PubMed Central
Figure 2 Mechanism of AMPK activation. AMPK can be activated via the LKB1 or CaMKKβ pathway (physiological activation) following phosphorylation at threonine 172 residue in the α subunit. It can also be activated exogenously by drugs such as quercetin and metformin that act on the mitochondria and increase the AMP:ATP ratio, which subsequently activates the LKB1-mediated phosphorylation and activation of AMPK. Lastly, it can also be activated allosterically by the binding of AMP at the AMPKγ subunit.
Figure 2 Mechanism of AMPK activation. AMPK can be activated via the LKB1 or CaMKKβ pathway (physiological activation) following phosphorylation at threonine 172 residue in the α subunit. It can also be activated exogenously by drugs such as quercetin and metformin that act on the mitochondria and increase the AMP:ATP ratio, which subsequently activates the LKB1-mediated phosphorylation and activation of AMPK. Lastly, it can also be activated allosterically by the binding of AMP at the AMPKγ subunit.CC BY · PubMed Central
Figure 3 Known mechanisms of activated AMPK-mediated downregulation of cyclin D1, cell cycle arrest, and autophagy. AMPK phosphorylation activates various cyclin-dependent kinases (CDKs) to result in downregulation of cyclin D1 and cell cycle arrest in the G1/S phase as well autophagy, all of which have been implicated in anticancer therapy.
Figure 3 Known mechanisms of activated AMPK-mediated downregulation of cyclin D1, cell cycle arrest, and autophagy. AMPK phosphorylation activates various cyclin-dependent kinases (CDKs) to result in downregulation of cyclin D1 and cell cycle arrest in the G1/S phase as well autophagy, all of which have been implicated in anticancer therapy.CC BY · PubMed Central
Figure 4 Activated AMPK-mediated downregulation of the mTORC1 complex can follow two pathways: through the phosphorylation and activation of tuberous sclerosis complex 2 (TSC 2) or via direct phosphorylation of raptor at S722 and S792. The deactivation of mTOR is subsequently followed by the inhibition of S6K1 and 4E-BP1, both of which are responsible for the initiation of protein translation and maintenance of cell size and growth.
Figure 4 Activated AMPK-mediated downregulation of the mTORC1 complex can follow two pathways: through the phosphorylation and activation of tuberous sclerosis complex 2 (TSC 2) or via direct phosphorylation of raptor at S722 and S792. The deactivation of mTOR is subsequently followed by the inhibition of S6K1 and 4E-BP1, both of which are responsible for the initiation of protein translation and maintenance of cell size and growth.CC BY · PubMed Central
Figure 5 Cellular pathways associated with AMPK activation in cancer and cancer stem cells. The figure depicts various important molecular pathways mediated by AMPK activation that play pivotal roles against cancer and cancer stem cells.
Figure 5 Cellular pathways associated with AMPK activation in cancer and cancer stem cells. The figure depicts various important molecular pathways mediated by AMPK activation that play pivotal roles against cancer and cancer stem cells.CC BY · PubMed Central
Figure 6 Structural similarity between phosphate and vanadate at physiological pH and the redox conversion between V (IV) and V (V) oxidation states.
Figure 6 Structural similarity between phosphate and vanadate at physiological pH and the redox conversion between V (IV) and V (V) oxidation states.CC BY · PubMed Central
Figure 7 Structures of some vanadium (IV) complexes with reported AMPK activation activity.
Figure 7 Structures of some vanadium (IV) complexes with reported AMPK activation activity.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 186 references

Research works printed but not linked: 1

  1. To, 2020, PTP1B inhibitory flavonoids from orthosiphon stamineus benth. and their growth inhibition on human breast cancer cells, Nat. Prod. Commun., 15, 1

Cited by

See all 33

Metadata

Authors
Uprety, B., & Abrahamse, H.
Affiliations
University of Johannesburg (ZA)
Corresponding author
Uprety, Bhawna
Venue
Cells
Publisher
MDPI AG
Published
2022-02-07
Volume
11
Issue
3
Pages
576
ISSN
2073-4409 (ISSN-L)
OpenAlex
W4210907560
Cited by
33
References
189
Citations by year
2026: 2 · 2025: 11 · 2024: 6 · 2023: 9 · 2022: 5
FWCI
0.81
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation of South Africa (98337)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Physical Sciences › Chemistry › Inorganic Chemistry › Vanadium and Halogenation Chemistry
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
breast cancer, cancer stem cells, AMPK activation, metformin, vanadium compounds, PTP1B inhibition, insulin mimetics, anticancer drug targets, stem cell-like properties
MeSH terms
Breast Neoplasms, Female, Humans, Neoplastic Stem Cells, Vanadium Compounds, AMP-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting Breast Cancer and Their Stem Cell Population through AMPK Activation: Novel Insights. https://app.cochat.ai/papers/10.3390/cells11030576
The paper
Uprety, B., & Abrahamse, H. (2022). Targeting Breast Cancer and Their Stem Cell Population through AMPK Activation: Novel Insights. Cells. https://doi.org/10.3390/cells11030576

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.